HEADER LYASE 13-JUL-14 4USW TITLE CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE WITH ATP COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENYLATE CYCLASE TYPE 10; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 1-469; COMPND 5 SYNONYM: AH-RELATED PROTEIN, ADENYLATE CYCLASE HOMOLOG, GERM CELL COMPND 6 SOLUBLE ADENYLYL CYCLASE, HSAC, SAC, TESTICULAR SOLUBLE ADENYLYL COMPND 7 CYCLASE; COMPND 8 EC: 4.6.1.1; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: BETA-MERCAPTOETHANOL MODIFICATION AT RESIDUE CYS253 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PVL1392 KEYWDS LYASE, ATP SUBSTRATE EXPDTA X-RAY DIFFRACTION AUTHOR S.KLEINBOELTING,C.STEEGBORN REVDAT 4 10-JAN-24 4USW 1 REMARK LINK REVDAT 3 03-APR-19 4USW 1 SOURCE LINK REVDAT 2 01-OCT-14 4USW 1 JRNL REVDAT 1 30-JUL-14 4USW 0 JRNL AUTH S.KLEINBOLTING,J.VAN DEN HEUVEL,C.STEEGBORN JRNL TITL STRUCTURAL ANALYSIS OF HUMAN SOLUBLE ADENYLYL CYCLASE AND JRNL TITL 2 CRYSTAL STRUCTURES OF ITS NUCLEOTIDE COMPLEXES -IMPLICATIONS JRNL TITL 3 FOR CYCLASE CATALYSIS AND EVOLUTION. JRNL REF FEBS J. V. 281 4151 2014 JRNL REFN ISSN 1742-464X JRNL PMID 25040695 JRNL DOI 10.1111/FEBS.12913 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 87.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 33478 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.167 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1775 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.10 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2508 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.2620 REMARK 3 BIN FREE R VALUE SET COUNT : 114 REMARK 3 BIN FREE R VALUE : 0.2890 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3610 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 202 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.77 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.06000 REMARK 3 B22 (A**2) : 0.06000 REMARK 3 B33 (A**2) : -0.20000 REMARK 3 B12 (A**2) : 0.03000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.160 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.151 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.114 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.649 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.967 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3780 ; 0.019 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3577 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5131 ; 1.999 ; 1.968 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8234 ; 0.922 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 467 ; 6.375 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 167 ;35.871 ;24.551 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 636 ;15.246 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;15.710 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 573 ; 0.120 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4227 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 869 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1843 ; 2.893 ; 3.003 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1840 ; 2.886 ; 3.002 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2299 ; 4.133 ; 4.479 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1937 ; 4.303 ; 3.575 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 467 REMARK 3 ORIGIN FOR THE GROUP (A): -11.0178 -32.1442 -1.0016 REMARK 3 T TENSOR REMARK 3 T11: 0.0387 T22: 0.0344 REMARK 3 T33: 0.0108 T12: 0.0229 REMARK 3 T13: 0.0186 T23: 0.0169 REMARK 3 L TENSOR REMARK 3 L11: 0.1726 L22: 0.2296 REMARK 3 L33: 0.3594 L12: -0.0076 REMARK 3 L13: -0.1686 L23: 0.0728 REMARK 3 S TENSOR REMARK 3 S11: 0.0509 S12: 0.0567 S13: 0.0345 REMARK 3 S21: 0.0423 S22: -0.0237 S23: 0.0093 REMARK 3 S31: -0.0549 S32: -0.0411 S33: -0.0271 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES WITH TLS ADDED ATP BUILD IN SYN CONFORMATION REMARK 3 ATP IN ANTI CONFORMATION IS ALSO PRESENT BUT WITH MINOR OCCUPANCY REMARK 4 REMARK 4 4USW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-JUL-14. REMARK 100 THE DEPOSITION ID IS D_1290061237. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUL-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.917050 REMARK 200 MONOCHROMATOR : SI111-DCM WITH SAGITTAL BENDER REMARK 200 OPTICS : COLLIMATOR REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35253 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 87.550 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.90000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.820 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 4CLK REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI REMARK 280 -SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL, PH 6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 48.37500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 48.37500 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 48.37500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 54500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -88.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 50.54500 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 -87.54651 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 -0.866025 0.000000 -50.54500 REMARK 350 BIOMT2 3 0.866025 -0.500000 0.000000 -87.54651 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 131 REMARK 465 THR A 132 REMARK 465 GLN A 133 REMARK 465 GLU A 134 REMARK 465 TRP A 135 REMARK 465 GLU A 136 REMARK 465 GLU A 137 REMARK 465 GLY A 138 REMARK 465 PRO A 351 REMARK 465 LYS A 468 REMARK 465 VAL A 469 REMARK 465 HIS A 470 REMARK 465 HIS A 471 REMARK 465 HIS A 472 REMARK 465 HIS A 473 REMARK 465 HIS A 474 REMARK 465 HIS A 475 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 130 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 139 CG CD1 CD2 REMARK 470 MET A 184 CG SD CE REMARK 470 LYS A 340 CG CD CE NZ REMARK 470 PHE A 350 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 353 CG CD OE1 OE2 REMARK 470 LYS A 354 CG CD CE NZ REMARK 470 LYS A 447 CG CD CE NZ REMARK 470 LYS A 451 CG CD CE NZ REMARK 470 ARG A 465 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 10 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 10 CB - CG - OD2 ANGL. DEV. = -8.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 10 53.95 -100.86 REMARK 500 ASP A 65 17.73 59.29 REMARK 500 ASP A 159 -159.50 -123.08 REMARK 500 ASN A 185 4.39 87.74 REMARK 500 ASP A 258 114.35 -169.15 REMARK 500 LYS A 378 -2.75 86.86 REMARK 500 ARG A 401 104.56 -163.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2049 DISTANCE = 6.00 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 ADENOSINE 5'-(TETRAHYDROGEN TRIPHOSPHATE) (ATP): SYN REMARK 600 CONFORMATION REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A1468 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 47 OD1 REMARK 620 2 ASP A 99 OD1 91.5 REMARK 620 3 ATP A1471 O2G 123.3 81.1 REMARK 620 4 ATP A1471 O1B 85.8 160.0 83.9 REMARK 620 5 HOH A2037 O 86.6 95.2 149.9 104.4 REMARK 620 6 HOH A2073 O 150.2 97.5 86.3 94.5 64.4 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 1468 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 1469 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 1470 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 1471 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1472 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UST RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE WITH REMARK 900 PYROPHOSPHATE RESULTING FROM SOAKING WITH GTP AND MAGNESIUM REMARK 900 RELATED ID: 4USU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE IN COMPLEX WITH REMARK 900 ALPHA,BETA-METHYLENEADENOSINE-5'-TRIPHOSPHATE REMARK 900 RELATED ID: 4USV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE WITH REMARK 900 PYROPHOSPHATE RESULTING FROM SOAKING WITH ATP AND CALCIUM DBREF 4USW A 1 469 UNP Q96PN6 ADCYA_HUMAN 1 469 SEQADV 4USW HIS A 470 UNP Q96PN6 EXPRESSION TAG SEQADV 4USW HIS A 471 UNP Q96PN6 EXPRESSION TAG SEQADV 4USW HIS A 472 UNP Q96PN6 EXPRESSION TAG SEQADV 4USW HIS A 473 UNP Q96PN6 EXPRESSION TAG SEQADV 4USW HIS A 474 UNP Q96PN6 EXPRESSION TAG SEQADV 4USW HIS A 475 UNP Q96PN6 EXPRESSION TAG SEQRES 1 A 475 MET ASN THR PRO LYS GLU GLU PHE GLN ASP TRP PRO ILE SEQRES 2 A 475 VAL ARG ILE ALA ALA HIS LEU PRO ASP LEU ILE VAL TYR SEQRES 3 A 475 GLY HIS PHE SER PRO GLU ARG PRO PHE MET ASP TYR PHE SEQRES 4 A 475 ASP GLY VAL LEU MET PHE VAL ASP ILE SER GLY PHE THR SEQRES 5 A 475 ALA MET THR GLU LYS PHE SER SER ALA MET TYR MET ASP SEQRES 6 A 475 ARG GLY ALA GLU GLN LEU VAL GLU ILE LEU ASN TYR HIS SEQRES 7 A 475 ILE SER ALA ILE VAL GLU LYS VAL LEU ILE PHE GLY GLY SEQRES 8 A 475 ASP ILE LEU LYS PHE ALA GLY ASP ALA LEU LEU ALA LEU SEQRES 9 A 475 TRP ARG VAL GLU ARG LYS GLN LEU LYS ASN ILE ILE THR SEQRES 10 A 475 VAL VAL ILE LYS CYS SER LEU GLU ILE HIS GLY LEU PHE SEQRES 11 A 475 GLU THR GLN GLU TRP GLU GLU GLY LEU ASP ILE ARG VAL SEQRES 12 A 475 LYS ILE GLY LEU ALA ALA GLY HIS ILE SER MET LEU VAL SEQRES 13 A 475 PHE GLY ASP GLU THR HIS SER HIS PHE LEU VAL ILE GLY SEQRES 14 A 475 GLN ALA VAL ASP ASP VAL ARG LEU ALA GLN ASN MET ALA SEQRES 15 A 475 GLN MET ASN ASP VAL ILE LEU SER PRO ASN CYS TRP GLN SEQRES 16 A 475 LEU CYS ASP ARG SER MET ILE GLU ILE GLU SER VAL PRO SEQRES 17 A 475 ASP GLN ARG ALA VAL LYS VAL ASN PHE LEU LYS PRO PRO SEQRES 18 A 475 PRO ASN PHE ASN PHE ASP GLU PHE PHE THR LYS CYS THR SEQRES 19 A 475 THR PHE MET HIS TYR TYR PRO SER GLY GLU HIS LYS ASN SEQRES 20 A 475 LEU LEU ARG LEU ALA CME THR LEU LYS PRO ASP PRO GLU SEQRES 21 A 475 LEU GLU MET SER LEU GLN LYS TYR VAL MET GLU SER ILE SEQRES 22 A 475 LEU LYS GLN ILE ASP ASN LYS GLN LEU GLN GLY TYR LEU SEQRES 23 A 475 SER GLU LEU ARG PRO VAL THR ILE VAL PHE VAL ASN LEU SEQRES 24 A 475 MET PHE GLU ASP GLN ASP LYS ALA GLU GLU ILE GLY PRO SEQRES 25 A 475 ALA ILE GLN ASP ALA TYR MET HIS ILE THR SER VAL LEU SEQRES 26 A 475 LYS ILE PHE GLN GLY GLN ILE ASN LYS VAL PHE MET PHE SEQRES 27 A 475 ASP LYS GLY CYS SER PHE LEU CYS VAL PHE GLY PHE PRO SEQRES 28 A 475 GLY GLU LYS VAL PRO ASP GLU LEU THR HIS ALA LEU GLU SEQRES 29 A 475 CYS ALA MET ASP ILE PHE ASP PHE CYS SER GLN VAL HIS SEQRES 30 A 475 LYS ILE GLN THR VAL SER ILE GLY VAL ALA SER GLY ILE SEQRES 31 A 475 VAL PHE CYS GLY ILE VAL GLY HIS THR VAL ARG HIS GLU SEQRES 32 A 475 TYR THR VAL ILE GLY GLN LYS VAL ASN LEU ALA ALA ARG SEQRES 33 A 475 MET MET MET TYR TYR PRO GLY ILE VAL THR CYS ASP SER SEQRES 34 A 475 VAL THR TYR ASN GLY SER ASN LEU PRO ALA TYR PHE PHE SEQRES 35 A 475 LYS GLU LEU PRO LYS LYS VAL MET LYS GLY VAL ALA ASP SEQRES 36 A 475 SER GLY PRO LEU TYR GLN TYR TRP GLY ARG THR GLU LYS SEQRES 37 A 475 VAL HIS HIS HIS HIS HIS HIS MODRES 4USW CME A 253 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 253 10 HET NA A1468 1 HET ACT A1469 4 HET ACT A1470 4 HET ATP A1471 31 HET GOL A1472 6 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM NA SODIUM ION HETNAM ACT ACETATE ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 NA NA 1+ FORMUL 3 ACT 2(C2 H3 O2 1-) FORMUL 5 ATP C10 H16 N5 O13 P3 FORMUL 6 GOL C3 H8 O3 FORMUL 7 HOH *202(H2 O) HELIX 1 1 TRP A 11 ALA A 18 1 8 HELIX 2 2 PRO A 21 TYR A 26 1 6 HELIX 3 3 GLY A 50 SER A 59 1 10 HELIX 4 4 SER A 60 MET A 64 5 5 HELIX 5 5 ARG A 66 PHE A 89 1 24 HELIX 6 6 GLU A 108 LYS A 110 5 3 HELIX 7 7 GLN A 111 LEU A 129 1 19 HELIX 8 8 GLY A 169 ALA A 182 1 14 HELIX 9 9 SER A 190 CYS A 197 1 8 HELIX 10 10 ASN A 225 THR A 235 1 11 HELIX 11 11 SER A 242 LYS A 246 5 5 HELIX 12 12 ARG A 250 LEU A 255 5 6 HELIX 13 13 ASP A 258 LYS A 267 1 10 HELIX 14 14 MET A 270 ASP A 278 1 9 HELIX 15 15 LEU A 282 SER A 287 5 6 HELIX 16 16 LYS A 306 PHE A 328 1 23 HELIX 17 17 LYS A 354 GLN A 375 1 22 HELIX 18 18 GLY A 408 TYR A 421 1 14 HELIX 19 19 ASP A 428 SER A 435 1 8 HELIX 20 20 PRO A 438 TYR A 440 5 3 SHEET 1 AA 5 ASP A 92 ALA A 97 0 SHEET 2 AA 5 ALA A 100 ARG A 106 -1 O ALA A 100 N ALA A 97 SHEET 3 AA 5 PHE A 35 SER A 49 -1 O VAL A 42 N TRP A 105 SHEET 4 AA 5 ARG A 142 GLY A 158 -1 O ARG A 142 N SER A 49 SHEET 5 AA 5 SER A 163 ILE A 168 1 O HIS A 164 N PHE A 157 SHEET 1 AB 7 ASP A 92 ALA A 97 0 SHEET 2 AB 7 ALA A 100 ARG A 106 -1 O ALA A 100 N ALA A 97 SHEET 3 AB 7 PHE A 35 SER A 49 -1 O VAL A 42 N TRP A 105 SHEET 4 AB 7 ARG A 142 GLY A 158 -1 O ARG A 142 N SER A 49 SHEET 5 AB 7 VAL A 187 LEU A 189 1 O ILE A 188 N LEU A 147 SHEET 6 AB 7 GLN A 210 LEU A 218 -1 O VAL A 213 N LEU A 189 SHEET 7 AB 7 ILE A 202 VAL A 207 -1 O GLU A 203 N ASN A 216 SHEET 1 AC 2 SER A 163 ILE A 168 0 SHEET 2 AC 2 ARG A 142 GLY A 158 1 O SER A 153 N ILE A 168 SHEET 1 AD 5 GLY A 330 MET A 337 0 SHEET 2 AD 5 CYS A 342 PHE A 348 -1 O SER A 343 N PHE A 336 SHEET 3 AD 5 GLU A 288 PHE A 301 -1 O THR A 293 N PHE A 348 SHEET 4 AD 5 ILE A 379 HIS A 398 -1 N GLN A 380 O MET A 300 SHEET 5 AD 5 ARG A 401 ILE A 407 1 O ARG A 401 N HIS A 398 SHEET 1 AE 7 GLY A 330 MET A 337 0 SHEET 2 AE 7 CYS A 342 PHE A 348 -1 O SER A 343 N PHE A 336 SHEET 3 AE 7 GLU A 288 PHE A 301 -1 O THR A 293 N PHE A 348 SHEET 4 AE 7 ILE A 379 HIS A 398 -1 N GLN A 380 O MET A 300 SHEET 5 AE 7 VAL A 425 CYS A 427 1 O THR A 426 N VAL A 386 SHEET 6 AE 7 TYR A 460 TYR A 462 -1 O TYR A 460 N CYS A 427 SHEET 7 AE 7 PHE A 442 GLU A 444 -1 O LYS A 443 N GLN A 461 SHEET 1 AF 2 ARG A 401 ILE A 407 0 SHEET 2 AF 2 ILE A 379 HIS A 398 1 O PHE A 392 N ILE A 407 LINK C ALA A 252 N CME A 253 1555 1555 1.35 LINK C CME A 253 N THR A 254 1555 1555 1.33 LINK OD1 ASP A 47 NA NA A1468 1555 1555 2.43 LINK OD1 ASP A 99 NA NA A1468 1555 1555 2.38 LINK NA NA A1468 O2G ATP A1471 1555 1555 2.11 LINK NA NA A1468 O1B ATP A1471 1555 1555 2.38 LINK NA NA A1468 O HOH A2037 1555 1555 1.95 LINK NA NA A1468 O HOH A2073 1555 1555 2.44 CISPEP 1 ARG A 33 PRO A 34 0 -1.80 SITE 1 AC1 5 ASP A 47 ASP A 99 ATP A1471 HOH A2037 SITE 2 AC1 5 HOH A2073 SITE 1 AC2 7 LYS A 95 HIS A 164 ASN A 333 LYS A 334 SITE 2 AC2 7 VAL A 335 GOL A1472 HOH A2069 SITE 1 AC3 7 LYS A 95 LEU A 166 VAL A 167 ARG A 176 SITE 2 AC3 7 PHE A 336 HOH A2095 HOH A2201 SITE 1 AC4 23 ASP A 47 ILE A 48 SER A 49 GLY A 50 SITE 2 AC4 23 PHE A 51 THR A 52 ALA A 97 GLY A 98 SITE 3 AC4 23 ASP A 99 LYS A 144 PHE A 336 PHE A 338 SITE 4 AC4 23 LEU A 345 THR A 405 VAL A 406 ASN A 412 SITE 5 AC4 23 ARG A 416 NA A1468 HOH A2038 HOH A2040 SITE 6 AC4 23 HOH A2072 HOH A2073 HOH A2168 SITE 1 AC5 11 HIS A 19 LYS A 95 PHE A 165 TYR A 268 SITE 2 AC5 11 LYS A 334 GLU A 403 ACT A1469 HOH A2009 SITE 3 AC5 11 HOH A2010 HOH A2069 HOH A2202 CRYST1 101.090 101.090 96.750 90.00 90.00 120.00 P 63 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009892 0.005711 0.000000 0.00000 SCALE2 0.000000 0.011423 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010336 0.00000